Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding
Sabin Vaccine Institute receives $35 million from BARDA with potential of up to $214 million for Medical Countermeasure Development against ...
Tag: Ebola
Officials Declare End to Ebola Outbreak in Uganda
After 142 confirmed cases of Ebola disease and 55 deaths, officials have declared an end to Uganda's Ebola outbreak. The ...
Texas Biomed at Forefront of Sudan ebolavirus Vaccine Development
A Sudan ebolavirus vaccine and antibody therapeutic tested at Texas Biomedical Research Institute have been sent to Uganda as part ...
How Prepared is Uganda for the Current Ebola Outbreak?
An outbreak of the deadly Ebola virus was announced by Uganda’s ministry of health on 21 September 2022. Uganda has ...
Stem Cell Research Gives New Clues on Ebola Virus Damage to Organs
The resulting liver cell model will be a valuable tool for future studies on Ebola virus vital organ pathology and ...
Ebola Virus Can ‘Hide Out’ in the Brain After Treatment and Cause Recurrent Infections
The Ebola virus can hide in the brains of monkeys that have recovered after medical treatment without causing symptoms and ...
USAMRIID Study Reveals Ebola Virus Can Hide in Brain
In a groundbreaking study, scientists describe how Ebola virus, which can persist in certain areas of the body, can re-emerge ...
Bucknell Researchers Head to Uganda to Study African Bats’ Immune Response to Ebola Virus
In 2021, Bucknell University biology professors DeeAnn Reeder and Ken Field received a $2.9 million grant from the National Institute ...
U.S. Plans to Expand Regional Ebola and Other Special Pathogen Treatment Centers
The U.S. Department of of Health and Human Services Assistant Secretary for Preparedness and Response (ASPR) has announced a forecasted ...
Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines
The Sabin Vaccine Institute (Sabin) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of ...
GeoVax Receives Patent for VLP Ebola Vaccine
GeoVax Labs, Inc. today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent ...
Duke University Develops Portable Diagnostic to Detect Early Biomarkers of Ebola Virus
An interdisciplinary team of scientists at Duke University has developed a highly sensitive and rapid diagnostic test for Ebola virus ...
Ebola Might Be a Chronic Infection – But Here’s Why We Shouldn’t Panic
Ebola is back in Guinea in West Africa, five years after the largest Ebola epidemic ever known ended – but ...
NBACC: Past Bioagent Research Informs Current and Future Pandemic Response
Like many U.S. research and development agencies, the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) was forced to shift ...
Ebola: CDC to Require Airlines to Collect Passenger Information if Traveling from DRC and Guinea
Starting Thursday, March 4, 2021, airlines and other aircraft operators will be required to collect and transmit contact information to ...
Why Ebola is Back in Guinea and Why the Response Must Be Different This Time
New reports of Ebola in Guinea are causing anxiety given the history of the West Africa outbreak of 2014-2016. This ...
Thin Film Freezing Shows Efficacy for Biodefense Countermeasures Against Alphaviruses and Filoviruses
TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented thin-film ...
Ebola Strikes West Africa Again: Key Questions and Lessons from the Past
News of a new outbreak of Ebola in Guinea is indeed distressing. The last in West Africa occurred between 2014 ...
One Drug to Defeat All Filoviruses?
While vaccines for Ebola virus are being deployed and show high efficacy, pan-filoviral treatment is still lacking. Researchers have identified ...
Human Spillover Potential of Reston Ebolavirus Noted by NIAID Study
New research shows pigs could serve as amplifying hosts for Reston ebolavirus. Reston ebolavirus (RESTV) should be considered a livestock ...
